Herbas VPB

Print
EN | LT
LT - ANTI-CD160 SPECIFIC ANTIBODIES FOR THE TREATMENT OF EYE DISORDERS BASED ON NEOANGIOGENESIS
EN - ANTI-CD160 SPECIFIC ANTIBODIES FOR THE TREATMENT OF EYE DISORDERS BASED ON NEOANGIOGENESIS

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 39/00
A61K 9/00
A61K 39/395
A61P 27/02
C07K 16/28
C07K 16/22
European patent
(11) Number of the document 2575881
(13) Kind of document T
(96) European patent application number 11728594.0
Date of filing the European patent application 2011-05-27
(97) Date of publication of the European application 2013-04-10
(45) Date of publication and mention of the grant of the patent 2016-09-14
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/EP2011/058777
Date 2011-05-27
PCT application publication
(87) Number WO 2011/147984
Date 2011-12-01
Priority applications
(30) Number Date Country code
349271 P 2010-05-28 US
Inventors
(72)
LE BOUTEILLER, Philippe, FR
BENSUSSAN, Armand, FR
Grantee
(73) INSERM - Institut National de la Santé et de la Recherche Médicale, 101, rue de Tolbiac, 75013 Paris, FR
Elsalys Biotech, 321 avenue Jean Jaures, 69007 Lyon, FR
Title
(54) ANTI-CD160 SPECIFIC ANTIBODIES FOR THE TREATMENT OF EYE DISORDERS BASED ON NEOANGIOGENESIS
  ANTI-CD160 SPECIFIC ANTIBODIES FOR THE TREATMENT OF EYE DISORDERS BASED ON NEOANGIOGENESIS
Last update date 2021-04-30